Researchers from the RAND Corporation — which took more than $15 million this year from a group financed by a Facebook co-founder — were a driving force behind the White House’s sweeping new AI reporting requirements.
WASHINGTON, Dec 14 (Reuters) — Twenty-eight healthcare companies, including CVS Health (CVS.N), are signing U.S. President Joe Biden’s voluntary commitments aimed at ensuring the safe development of artificial intelligence (AI), a White House official said on Thursday.
The commitments by healthcare providers and payers follow those of 15 leading AI companies, including Google, OpenAI and OpenAI partner Microsoft (MSFT.O) to develop AI models responsibly.
Biden’s government is pushing to set parameters around AI as it makes rapid gains in capability and popularity while regulation remains limited.
The OpenAI Chief Scientist’s status remains unclear, but his “Superalignment” team put out a groundbreaking paper on the path to AGI.
A new research paper out of OpenAI Thursday says a superhuman AI is coming, and the company is developing tools to ensure it doesn’t turn against humans.
Who’s Afraid of AI—and Why?
Posted in robotics/AI
We live in an era where machines increasingly perform functions once restricted to humans.
Artificial Intelligence.
Who’s Afraid of AI—and Why?
A growing body of research sheds light on our reactions to AI and automation.
In November 2022, OpenAI launched ChatGPT.
From President Biden’s executive order on AI to the E.U. AI Act, governments scrambled to regulate AI this year.
The poster child for generative AI software is a startling human mimic. It represents a potential new era in research, but brings risks.
AI is fueling a revolution in science that may change our definition of understanding itself.
Artificial intelligence is changing the way some scientists conduct research, leading to new discoveries on accelerated timetables.
The pursuit of rewards can lead to addiction and insensitivity to pleasure, but managing neurochemistry and focusing on the process can help achieve fulfillment and reduce addiction.
Questions to inspire discussion.
What can the pursuit of rewards lead to?
—The pursuit of rewards can lead to addiction and insensitivity to pleasure.
Anna Lembke is a psychiatrist who is Chief of the Stanford Addiction Medicine Dual Diagnosis Clinic at Stanford University and an author. Dopamine is a key neurotransmitter in our reward pathway. It tells us when to feel pleasure and pain, it can cause depression and anxiety, and it’s being hijacked by the modern world. Phones, video games, porn, food, our world is filled with cheap dopamine, which in turn is making us miserable. Expect to learn how dopamine creates a see-saw balance of pleasure and pain, why cravings to use your phone are driven by dopamine, the truth about dopamine detoxing, how to reset your brain’s dopamine balance, the most successful interventions for changing your relationship to dopamine long term and much more…
Our guest today has updated his financial and business model for Tesla Bot Gen 2. With these new capabilities, what are the use cases and what’s the forecast for Tesla’s revenue and margins. Follow Cern on X: @CernBasher Website: BrilliantAdvice.net My website: https://www.herbertong.com Get Free TESLA Milestone Tables Check out 15+ modules of resources for the $TSLA Investor Join this channel or Patreon to get access to perks: Get free access to 15+ modules of TSLA investor resources Become a member: https://www.youtube.com/channel/UC4DBLlq1x0AKmip1QJUcbXg/join Join my Patreon: https://www.patreon.com/brighterwithherbert Use my referral link to buy a Tesla product: https://ts.la/herbert23392 ❤️ Thank you to everyone who supports me and this channel! I really do appreciate your likes, subscribes and comments. Let’s get brighter! Website: www.herbertong.